Researchers have shed new light on how a type of heart valve disease -- aortic valve stenosis -- progresses differently in males and females.

Patients with symptomatic severe aortic stenosis undergoing CoreValve or Evolut TAVI have better 5-year bioprosthetic valve ...

Aortic stenosis, a narrowing of the aortic valve, is one of the most common and severe structural issues, particularly in ...

Dr Rajneesh Kapoor highlights the evolution of structural heart disease treatments, exploring the impact of transcatheter ...

A recent study has highlighted the sex-specific implications of myocardial fibrosis on mortality in patients with severe ...

A STUDY assessing coronary proximity in patients undergoing transcatheter pulmonary valve replacement (TPVR) with ...

Medtronic has announced the SMART trial’s two-year outcomes of Evolut TAVR for aortic stenosis (AS) and small aortic annulus.

Medtronic released positive two-year trial Evolut TAVR results that demonstrated superior valve performance in small aortic ...

Propranolol and metoprolol are beta-blockers taking to treat certain heart conditions. Learn more about their similarities ...

Charlotte has been in and out of the hospital for much of her young life. Her mother, Laci, said Charlotte would have blue ...

WICHITA FALLS, Texas (KAUZ) - The United Regional Health Care System is celebrating a major milestone in cardiovascular care ...